Report overview
Nano biotechnology combines nano technology and biotechnology including special physicochemical and biological properties of nanostructures and their applications in numerous fieldslike medicine and agriculture. Nanobiotechnology is one of the most promising technologies in the 21st century. It plays a major role in developing and implementing many useful tools in the study of life. Its application in medicine involves disease diagnosis, target-specific drug delivery and molecular imaging. It also has application in agriculture and food. The factors such as increasing demand for the innovative drug in the pharmaceutical industry, rise in the application of nano biotechnology electronics, energy production and biomaterials and increased research & development investment are the key drivers of the global nano biotechnology market.
This report aims to provide a comprehensive presentation of the global market for NanoBioTechnology (NBT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NanoBioTechnology (NBT). This report contains market size and forecasts of NanoBioTechnology (NBT) in global, including the following market information:
Global NanoBioTechnology (NBT) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global NanoBioTechnology (NBT) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
0-10 nm Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NanoBioTechnology (NBT) include Ablynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTecbioanalytics GmbH (Germany) and Nanobiotix(France), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NanoBioTechnology (NBT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NanoBioTechnology (NBT) Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, by Type, 2022 (%)
0-10 nm
10-100 nm
Global NanoBioTechnology (NBT) Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, by Application, 2022 (%)
Pharmaceuticals
Medical Research
Food and Agriculture
Others
Global NanoBioTechnology (NBT) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NanoBioTechnology (NBT) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NanoBioTechnology (NBT) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ablynx (Belgium)
Nami Therapeutics (US)
Celgene Corporation (US)
Nanophase Technologies Corporation (US)
Sigma-Aldrich (US)
SkyePharma Pharmaceuticals (France)
Nano Bridging Molecules SA (Switzerland)
XanTecbioanalytics GmbH (Germany)
Nanobiotix(France)
Dabur Pharma (India)
Outline of Major Chapters:
Chapter 1: Introduces the definition of NanoBioTechnology (NBT), market overview.
Chapter 2: Global NanoBioTechnology (NBT) market size in revenue.
Chapter 3: Detailed analysis of NanoBioTechnology (NBT) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NanoBioTechnology (NBT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
